...
机译:新型非共价哌啶肽蛋白酶体抑制剂的设计,合成和生物学评价
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Proteasome inhibitors; Piperidine; Non-covalent; Anti-cancer; SARs;
机译:新型非共价哌啶肽蛋白酶体抑制剂的设计,合成和生物学评价
机译:β-氨基酸组成的肽基环氧酮蛋白酶体抑制剂的设计,合成及生物学评价
机译:新型酚醛醚衍生物作为非共价蛋白酶体抑制剂的设计,合成和生物学评价
机译:Nedd4 E3泛素连接酶小分子抑制剂的设计,合成和生物学评估
机译:第一部分。设计用于人类颗粒酶B(hBrB)的新型可逆非共价小分子抑制剂。第二部分。姜黄素和模拟物作为蛋白酶体抑制剂第三部分。新型的针对雌激素受体α的共激活因子结合抑制剂(CBI)的设计:打破1μM的障碍。
机译:针对多发性骨髓瘤的骨靶向蛋白酶体抑制剂的设计合成和生物学评估
机译:新型可逆性肽基FVIIa抑制剂的设计,合成及生物活性Rh催化对映选择性合成二芳基胺